- Home
- usa massachusetts
- Companies
Refine by
Medical Industry Technology In Massachusetts
34 companies found
Technologybased inGaithersburg, MASSACHUSETTS (USA)
In November 2023, Selecta Biosciences Inc. (NASDAQ: SELB) merged with Cartesian Therapeutics to create a publicly traded company pioneering RNA cell therapy to treat autoimmune disease. The combined company will focus on advancing Cartesian’s wholly ...
Selecta’s wholly owned gene therapy program for the treatment of ornithine transcarbamylase (OTC) deficiency is expected to enter the clinic in 2022. OTC deficiency is a genetic disorder urea cycle that causes ammonia to accumulate in the ...
Technologybased inBoston, MASSACHUSETTS (USA)
Neoclease is at the forefront of advancing gene editing technologies with a mission to transform healthcare by curing genetic diseases rather than just treating them. Utilizing a bespoke approach, the company develops tailored nucleases designed to ...
Technologybased inBoston, MASSACHUSETTS (USA)
Like our customers and their consumers, we needed a real change in the probiotic world that would result in products with benefits we can all feel. We knew current probiotics on the market deliver unpredictable benefits for some people, while not ...
Yso3 is a preclinical drug development program aimed at treating asthma. Using a revolutionary form of living biotherapy targeting the lung, YSOPIA is pioneering the innovative field of the lung microbiome. As part of this program, YSOPIA has ...
Technologybased inCambridge, MASSACHUSETTS (USA)
Vaxxas is commercializing novel technology that dramatically enhances the performance of existing and next-generation vaccines. The company believes its innovative needle-free technology will be fundamental to help the world in rethinking what's ...
Vaxxas is commercializing a novel vaccination technology that dramatically enhances the performance of existing and next-generation vaccines. The core of Vaxxas technology platform is a High Density Microarray Patch (HD-MAP). Vaxxas' HD-MAP is ...
Technologybased inCambridge, MASSACHUSETTS (USA)
We are a cell therapy company that combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. Vor, the Norse goddess of wisdom, was known as the careful one. ...
Our first multi-targeted Treatment System is comprised of VOR33-CLL1 multiplex-edited eHSC therapy and VCAR33-CLL1 multi-specific CAR-T therapy. Knocking out CD33 and CLL-1 through gene editing offers a promising new approach to treating patients ...
Technologybased inCambridge, MASSACHUSETTS (USA)
Myeloid Therapeutics is a leader in the development of mRNA-based immunotherapies, focusing on harnessing and enhancing the natural capabilities of myeloid cells to combat cancer. The company's cutting-edge in vivo engineering platform is designed ...
Myeloid is focused on advancing its ATAK CAR monocytes, which are myeloid cells with innate immune receptor-inspired CARs to recognize and kill cancer. Additionally, Myeloid has streamlined manufacturing for its ATAK cell therapy candidates through ...
Technologybased inHamburg, GERMANY
Revvity Gene Delivery (formerly SIRION Biotech) supports your cell and gene therapy development process ̶ offering solutions for early R&D all the way to clinical applications, with easy transfer of processes and assays into GMP production. ...
Revvity’s gene delivery team, where SIRION Biotech’s expertise lives on, has been partnering with pharma and biotech organizations for many years to provide improved viral vectors using our AAV ...
Technologybased inMilano, ITALY
InnovHeart, with locations in Milan, Italy, and Boston, Massachusetts, develops transcatheter mitral valve replacement (TMVR) systems to treat patients suffering from mitral valve disease. The company is currently in clinical trials testing its ...
The Mitral Valve is a complex structure positioned between the left atrium and the left ventricle. Its function is to make unidirectional the blood flow from the left atrium to the left ventricle. The Mitral Valve can be affected by two major ...
Technologybased inBoston, MASSACHUSETTS (USA)
We can create human tissues and organs using cells from our own bodies, paving the way to make us our own organ donors, reducing organ rejection and solve the problem with lack of donors. We can save lives with faster and more accurate methods for ...
Enabling high-throughput 3D cell culturing and bioprinting to create the future of health. The epitome of user-friendly flexibility. Bioprint with more materials for even more complex models. Independent dual pressure that enables coaxial and mixing ...
Technologybased inDanvers, MASSACHUSETTS (USA)
Abiomed is a leading provider of groundbreaking medical technology that provides circulatory and oxygenation support. The Impella® heart pump platform is designed to enable the heart to rest and recover by improving blood flow and/or temporarily ...
A heart pump designed for surgeons with forward flow and intelligent patient management. Impella 5.5 with SmartAssist delivers full cardiac support with maximum unloading, allowing the heart to rest and recover. It is a microaxial, surgically ...
Technologybased inLexington, MASSACHUSETTS (USA)
At T2 Biosystems, our mission is to save lives and improve healthcare by empowering clinicians to get patients on the right therapy faster. We come to work every day to solve critical needs in healthcare diagnostics with innovative solutions built ...
The T2SARS-CoV-2 Panel, run on the T2Dx® Instrument, is a qualitative reverse transcriptase-polymerase chain reaction (RT-PCR) and T2 Magnetic Resonance (T2MR®) test. This test is designed for the direct detection of nucleic acid from ...
Technologybased inBoston, MASSACHUSETTS (USA)
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — ...
We’re investigating other potential small molecule medicines aimed at treating the underlying cause of CF. VX-561 (deutivacaftor) is an investigational once daily potentiator designed to keep CFTR proteins at the cell surface open longer to ...
Technologybased inAddington, NEW ZEALAND
Izon Science brings precision and reproducibility to the world of nanoparticle separation and analysis for biological research and nanomedicine development. The qEV isolation platform is the trusted method for isolating extracellular vesicles (EVs), ...
Optimising blood-based extracellular vesicle (EV) biomarkers? ?Tapping into the therapeutic potential of milk EVs or cell culture EVs? Separating labelled EVs from unbound dye? The qEV isolation platform is incredibly versatile. We offer customised ...
Technologybased inCambridge, MASSACHUSETTS (USA)
Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD) and improving the ...
Supporting your clinical research program. By teaming up with our Clinical Services team, you can reduce time to clinical trial activation while improving clinical research ...
Technologybased inParis, FRANCE
TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: To reconstruct damaged tissue and restore its natural function. Our mission is to disrupt the field of surgery and ...
Our proprietary biomorphic programmable polymers enable tissue reconstruction and can be adapted for use in multiple clinical ...
Technologybased inMaynard, MASSACHUSETTS (USA)
NorthEast Monitoring is committed to advancing Holter technology with our innovative ambulatory cardiac hardware and software solutions. We created the world’s FIRST 14-DAY Holter and event recorder, provide flexible licensing models for our ...
Technologybased inRehovot, ISRAEL
Biolojic Design is committed to curing patients by designing and developing a pipeline of revolutionary therapeutics. Biolojic’s platform generates antibodies that bind to predefined epitopes, thus allowing for the design of specific functions: ...
Redefining What Antibodies Can Do: Biolojic’s platform generates antibodies that bind to predefined epitopes, thus allowing for the design of specific functions: agonism, antagonism and selective binding. The platform also generates ...
Technologybased inFramingham, MASSACHUSETTS (USA)
Kephera Diagnostics is a startup that aims to address the public health challenges of global infectious diseases with point of care assay technology. We collaborate with a global community of researchers to develop and translate new technologies ...
Technologybased inCambridge, MASSACHUSETTS (USA)
Founded in 2018 by a team of accomplished scientists with a proven track record in drug discovery and executive leadership in top global biopharmaceutical companies, Regor is a pioneering international biotech company with headquarters in Shanghai, ...
rCARD™, Computer Accelerated Rational Discovery, is a powerful and proprietary technology platform currently under development at Regor. We have hired a team of experienced computational chemists and structural biologists trained at ...
Technologybased inIndianapolis, INDIANA (USA)
Lilly was founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that met real needs in an era of unreliable elixirs peddled by questionable characters. His charge to the generations of employees who have followed ...
Our Shielded Living Therapeutics platform combines advanced cell engineering with innovations in biocompatible materials, potentially enabling our products to produce a wide range of therapeutic molecules that may be missing or deficient in the ...
